Veterans’ RightsAn independent resource for veterans
← All decisions
GrantedPACT Act

The Veteran's prostate cancer resulted in erectile dysfunction without penile deformity, and a separate noncompensable rating for this condition was granted. The Veteran also received a 100% evaluation for his prostate cancer effective August 4, 2023.

The deciding factor: The evidence did not show that the Veteran met the requirements for a compensable rating from November 1, 2003 to July 17, 2007 and a higher rating is not warranted. The Veteran's prostate cancer residuals were rated as voiding dysfunction due to incontinence.

Claimed conditions
prostate cancer, erectile dysfunction
How they argued it
Not specified
Exposure basis
None
Rating assigned
100%
Decision date
April 17, 2024
Citation
24016583

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 24016583.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.